Merck Q3 KEYTRUDA/KEYTRUDA QLEX Sales $8.60B (+6% Y/Y)

Benzinga · 3d ago

Total Worldwide Sales Were $18.1 Billion (5% Growth; 4% Growth ex-FX)

  • KEYTRUDA/KEYTRUDA QLEX1 Sales Were $8.6 Billion (6% Growth; 6% Growth ex-FX); Includes KEYTRUDA QLEX Sales of $830 Million
  • WINREVAIR Sales Were $694 Million (93% Growth; 94% Growth ex-FX)
  • Animal Health Sales Were $1.7 Billion (4% Growth; 3% Growth ex-FX)